acyclovir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
63187-192 -
Package NDC
63187-192-30 -
Package NDC
63187-192-35 -
Package NDC
63187-192-60 -
Package NDC
63187-192-90 -
Application number
ANDA077309 -
SPL ID
9c66b198-9eb5-4e9d-89f9-c765eaeb9c69 -
SPL set ID
4c5a75fa-73db-4f48-895f-de1635d33f49 -
UNII
X4HES1O11F -
RxCUI
197313
What the source publishes
- Labeler
- Proficient Rx LP
- Active ingredients
- acyclovir
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "acyclovir",
"splId": "9c66b198-9eb5-4e9d-89f9-c765eaeb9c69",
"labels": [
{
"setId": "4c5a75fa-73db-4f48-895f-de1635d33f49",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c5a75fa-73db-4f48-895f-de1635d33f49",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c5a75fa-73db-4f48-895f-de1635d33f49"
}
],
"routes": [
"ORAL"
],
"labeler": "Proficient Rx LP",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (63187-192-30)",
"package_ndc": "63187-192-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20190101"
},
{
"sample": false,
"description": "35 TABLET in 1 BOTTLE (63187-192-35)",
"package_ndc": "63187-192-35",
"identifierStatus": "well-formed",
"marketing_start_date": "20190101"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (63187-192-60)",
"package_ndc": "63187-192-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20190101"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (63187-192-90)",
"package_ndc": "63187-192-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20190101"
}
],
"productId": "63187-192_9c66b198-9eb5-4e9d-89f9-c765eaeb9c69",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "63187-192",
"deaSchedule": null,
"genericName": "acyclovir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ACYCLOVIR",
"strength": "800 mg/1"
}
],
"applicationNumber": "ANDA077309",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20060313",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000020060",
"N0000180187",
"N0000180188",
"N0000175468",
"N0000175459"
],
"unii": [
"X4HES1O11F"
],
"rxcui": [
"197313"
],
"spl_set_id": [
"4c5a75fa-73db-4f48-895f-de1635d33f49"
],
"pharm_class_epc": [
"Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"
],
"pharm_class_moa": [
"DNA Polymerase Inhibitors [MoA]"
],
"manufacturer_name": [
"Proficient Rx LP"
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:63187-192_9c66b198-9eb5-4e9d-89f9-c765eaeb9c69"